votoplam
votoplam: 1 clinical trial tracked.
votoplam evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about votoplam, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Clinical Trial Registry Records (1)
A Randomized, Placebo-controlled, Double-blind Phase 3 Study to Evaluate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
Primary endpoint: Change from Baseline in cUHDRS score
InterventionalRandomizedquadruple770 targetStarted 2026-03Completion 2030-0450 sites · Argentina, Australia, Belgium, Bulgaria…Novartis Pharmaceuticals